1. Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, et al.; ESC Scientific Document Group. 2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed By: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36(42):2921-64. https://doi.org/10.1093/eurheartj/ehv318 https://pubmed.ncbi.nlm.nih.gov/26320112 
2. Maisch B, Seferović PM, Ristić AD, Erbel R, Rienmüller R, Adler Y, et al.; Task Force on the Diagnosis and Management of Pricardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J. 2004;25(7):587-610. https://doi.org/10.1016/j.ehj.2004.02.002 https://pubmed.ncbi.nlm.nih.gov/15120056 
3. Imazio M, Cecchi E, Demichelis B, Ierna S, Demarie D, Ghisio A, et al. Indicators of poor prognosis of acute pericarditis. Circulation. 2007;115(21):2739-44. https://doi.org/10.1161/CIRCULATIONAHA.106.662114 https://pubmed.ncbi.nlm.nih.gov/17502574 
4. Imazio M, Demichelis B, Parrini I, Giuggia M, Cecchi E, Gaschino G, et al. Day-hospital treatment of acute pericarditis: a management program for outpatient therapy. J Am Coll Cardiol. 2004;43(6):1042-6. https://doi.org/10.1016/j.jacc.2003.09.055 https://pubmed.ncbi.nlm.nih.gov/15028364 
5. Černe A, Poglajen G, Lejko Zupanc T, Berden P, Koželj M. Predlog obravnave bonika s sumom na miokarditis. Slov Kardiol. 2014;11(1):52-61. 
6. Imazio M, Brucato A, Derosa FG, Lestuzzi C, Bombana E, Scipione F, et al. Aetiological diagnosis in acute and recurrent pericarditis: when and how. J Cardiovasc Med (Hagerstown). 2009;10(3):217-30. https://doi.org/10.2459/JCM.0b013e328322f9b1 https://pubmed.ncbi.nlm.nih.gov/19262208 
7. Cosyns B, Plein S, Nihoyanopoulos P, Smiseth O, Achenbach S, Andrade MJ, et al.; European Association of Cardiovascular Imaging (EACVI); European Society of Cardiology Working Group (ESC WG) on Myocardial and Pericardial diseases. European Association of Cardiovascular Imaging (EACVI) position paper: multimodality imaging in pericardial disease. Eur Heart J Cardiovasc Imaging. 2015;16(1):12-31. https://doi.org/10.1093/ehjci/jeu128 https://pubmed.ncbi.nlm.nih.gov/25248336 
8. Imazio M, Adler Y. Pharmacological therapy of pericardial diseases. Curr Pharm Des. 2015;21(4):525-30. https://doi.org/10.2174/138161282104141204144622 https://pubmed.ncbi.nlm.nih.gov/25483954 
9. Imazio M, Brucato A, Cemin R, Ferrua S, Maggiolini S, Beqaraj F, et al.; ICAP Investigators. A randomized trial of colchicine for acute pericarditis. N Engl J Med. 2013;369(16):1522-8. https://doi.org/10.1056/NEJMoa1208536 https://pubmed.ncbi.nlm.nih.gov/23992557 
10. Imazio M, Brucato A, Cumetti D, Brambilla G, Demichelis B, Ferro S, et al. Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation. 2008;118(6):667-71. https://doi.org/10.1161/CIRCULATIONAHA.107.761064 https://pubmed.ncbi.nlm.nih.gov/18645054 
11. Imazio M, Belli R, Brucato A, Cemin R, Ferrua S, Beqaraj F, et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial. Lancet. 2014;383(9936):2232-7. https://doi.org/10.1016/S0140-6736(13)62709-9 https://pubmed.ncbi.nlm.nih.gov/24694983 
12. Imazio M, Adler Y, Charron P. Recurrent Pericarditis: modern Approach in 2016. Curr Cardiol Rep. 2016;18(6):50. https://doi.org/10.1007/s11886-016-0727-8 https://pubmed.ncbi.nlm.nih.gov/27108360 
13. Moretti M, Buiatti A, Merlo M, Massa L, Fabris E, Pinamonti B, et al. Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. Am J Cardiol. 2013;112(9):1493-8. https://doi.org/10.1016/j.amjcard.2013.06.036 https://pubmed.ncbi.nlm.nih.gov/23972350 
14. Imazio M, Andreis A, De Ferrari GM, et al. Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: the IRAP study. Eur J Prev Cardiol. 2019;27(9):1-9. https://doi.org/10.1177/2047487319879534 https://pubmed.ncbi.nlm.nih.gov/31610707 
15. Vianello F, Cinetto F, Cavraro M, Battisti A, Castelli M, Imbergamo S, et al. Azathioprine in isolated recurrent pericarditis: a single centre experience. Int J Cardiol. 2011;147(3):477-8. https://doi.org/10.1016/j.ijcard.2011.01.027 https://pubmed.ncbi.nlm.nih.gov/21296434 
16. Khandaker MH, Schaff HV, Greason KL, Anavekar NS, Espinosa RE, Hayes SN, et al. Pericardiectomy vs medical management in patients with relapsing pericarditis. Mayo Clin Proc. 2012;87(11):1062-70. https://doi.org/10.1016/j.mayocp.2012.05.024 https://pubmed.ncbi.nlm.nih.gov/23127733 
17. Imazio M, Brucato A, Barbieri A, Ferroni F, Maestroni S, Ligabue G, et al. Good prognosis for pericarditis with and without myocardial involvement: results from a multicenter, prospective cohort study. Circulation. 2013;128(1):42-9. https://doi.org/10.1161/CIRCULATIONAHA.113.001531 https://pubmed.ncbi.nlm.nih.gov/23709669 
18. Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al.; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636-48. https://doi.org/10.1093/eurheartj/eht210 https://pubmed.ncbi.nlm.nih.gov/23824828 
19. Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, et al.; Coxib and traditional NSAID Trialists’ (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382(9894):769-79. https://doi.org/10.1016/S0140-6736(13)60900-9 https://pubmed.ncbi.nlm.nih.gov/23726390 
20. Imazio M, Adler Y. Management of pericardial effusion. Eur Heart J. 2013;34(16):1186-97. https://doi.org/10.1093/eurheartj/ehs372 https://pubmed.ncbi.nlm.nih.gov/23125278 
21. Sagristà-Sauleda J, Angel J, Permanyer-Miralda G, Soler-Soler J. Long-term follow-up of idiopathic chronic pericardial effusion. N Engl J Med. 1999;341(27):2054-9. https://doi.org/10.1056/NEJM199912303412704 https://pubmed.ncbi.nlm.nih.gov/10615077 
22. Ristić AD, Imazio M, Adler Y, Anastasakis A, Badano LP, Brucato A, et al. Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2014;35(34):2279-84. https://doi.org/10.1093/eurheartj/ehu217 https://pubmed.ncbi.nlm.nih.gov/25002749 
23. Imazio M, Brucato A, Adler Y, Brambilla G, Artom G, Cecchi E, et al. Prognosis of idiopathic recurrent pericarditis as determined from previously published reports. Am J Cardiol. 2007;100(6):1026-8. https://doi.org/10.1016/j.amjcard.2007.04.047 https://pubmed.ncbi.nlm.nih.gov/17826391 
24. Syed FF, Schaff HV, Oh JK. Constrictive pericarditis—a curable diastolic heart failure. Nat Rev Cardiol. 2014;11(9):530-44. https://doi.org/10.1038/nrcardio.2014.100 https://pubmed.ncbi.nlm.nih.gov/25072910 
25. Mahfoud F, Gärtner B, Kindermann M, Ukena C, Gadomski K, Klingel K, et al. Virus serology in patients with suspected myocarditis: utility or futility? Eur Heart J. 2011;32(7):897-903. https://doi.org/10.1093/eurheartj/ehq493 https://pubmed.ncbi.nlm.nih.gov/21217143 
26. Reuter H, Burgess LJ, Louw VJ, Doubell AF. The management of tuberculous pericardial effusion: experience in 233 consecutive patients. Cardiovasc J S Afr. 2007;18(1):20-5. https://pubmed.ncbi.nlm.nih.gov/17392991 
27. Augustin P, Desmard M, Mordant P, Lasocki S, Maury JM, Heming N, et al. Clinical review: intrapericardial fibrinolysis in management of purulent pericarditis. Crit Care. 2011;15(2):220. https://doi.org/10.1186/cc10022 https://pubmed.ncbi.nlm.nih.gov/21575282 
28. Alpert MA, Ravenscraft MD. Pericardial involvement in end-stage renal disease. Am J Med Sci. 2003;325(4):228-36. https://doi.org/10.1097/00000441-200304000-00009 https://pubmed.ncbi.nlm.nih.gov/12695728 
29. Imazio M. Idiopathic recurrent pericarditis as an immune-mediated disease: current insights into pathogenesis and emerging treatment options. Expert Rev Clin Immunol. 2014;10(11):1487-92. https://doi.org/10.1586/1744666X.2014.965150 https://pubmed.ncbi.nlm.nih.gov/25307995 
30. Imazio M, Brucato A, Ferrazzi P, Pullara A, Adler Y, Barosi A, et al.; COPPS-2 Investigators. Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial. JAMA. 2014;312(10):1016-23. https://doi.org/10.1001/jama.2014.11026 https://pubmed.ncbi.nlm.nih.gov/25172965 
31. Imazio M, Brucato A, Markel G, Cemin R, Trinchero R, Spodick DH, et al. Meta-analysis of randomized trials focusing on prevention of the postpericardiotomy syndrome. Am J Cardiol. 2011;108(4):575-9. https://doi.org/10.1016/j.amjcard.2011.03.087 https://pubmed.ncbi.nlm.nih.gov/21624554 
32. Holmes DR, Nishimura R, Fountain R, Turi ZG. Iatrogenic pericardial effusion and tamponade in the percutaneous intracardiac intervention era. JACC Cardiovasc Interv. 2009;2(8):705-17. https://doi.org/10.1016/j.jcin.2009.04.019 https://pubmed.ncbi.nlm.nih.gov/19695538 
33. Lancellotti P, Nkomo VT, Badano LP, Bergler-Klein J, Bogaert J, Davin L, et al.; American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2013;26(9):1013-32. https://doi.org/10.1016/j.echo.2013.07.005 https://pubmed.ncbi.nlm.nih.gov/23998694 
34. Maisch B, Ristic A, Pankuweit S. Evaluation and management of pericardial effusion in patients with neoplastic disease. Prog Cardiovasc Dis. 2010;53(2):157-63. https://doi.org/10.1016/j.pcad.2010.06.003 https://pubmed.ncbi.nlm.nih.gov/20728703 
35. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344(7):501-9. https://doi.org/10.1056/NEJM200102153440707 https://pubmed.ncbi.nlm.nih.gov/11172193 
36. Fenstad ER, Le RJ, Sinak LJ, Maradit-Kremers H, Ammash NM, Ayalew AM, et al. Pericardial effusions in pulmonary arterial hypertension: characteristics, prognosis, and role of drainage. Chest. 2013;144(5):1530-8. https://doi.org/10.1378/chest.12-3033 https://pubmed.ncbi.nlm.nih.gov/23949692 
37. Imazio M, Brucato A, Rampello S, Armellino F, Trinchero R, Spodick DH, et al. Management of pericardial diseases during pregnancy. J Cardiovasc Med (Hagerstown). 2010;11(8):557-62. https://doi.org/10.2459/JCM.0b013e3283352356 https://pubmed.ncbi.nlm.nih.gov/20389257 
38. Maisch B, Ristic AD, Seferovic M, Tsang SM. Interventional pericardiology: peri- cardiocentesis, pericardioscopy, pericardial biopsy, balloon pericardiotomy, and intrapericardial therapy. Heidelberg: Springer; 2011. https://doi.org/10.1007/978-3-642-11335-2 
